Building local pharmaceutical capacity
EABB’s proposed pharmaceutical manufacturing initiative in South Sudan brings together KSK Company Limited and Cairo-based JLK Company. The initiative has an initial projected investment capital of US$50 million.
Preparing for industrial development
The proposed site comprises 10,000 square metres of land in Juba owned by KSK Company Limited. By 2023, preparation included legal documentation and technical and economic feasibility studies.
These preparatory stages help define the technical and commercial requirements of the proposed facility.
Connecting healthcare and investment
The initiative forms part of EABB’s health infrastructure activities, alongside medical equipment within our general supplies business.
Explore the pharmaceutical manufacturing initiative or contact our team to discuss the project and potential collaboration.
Illustrative laboratory photography: National Cancer Institute / Daniel Sone via Unsplash.
